This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Engineered autophagy receptors administered with extracellular vesicles eliminate pathological Tau and TDP-43.
Nature biomedical engineering · 2026
Antibody targeting TDP-43 mitigates pathogenic pathways induced by the cerebrospinal fluid of ALS.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
Tryptophan residues in TDP-43 and SOD1 modulate the cross-seeding and toxicity of SOD1.
The Journal of biological chemistry · 2024
Latest funding
- $1,224,000
Cellular communication in Amyotrophic Lateral Sclerosis: untangling a unique astrocytic pathway leading to neurodegeneration and neuroinflammation.
CIHR · 2025 · Nominated PI
- $600,000
Canada Research Chairs - Tier 2
CIHR · 2022 · Nominated PI
- $12,500
Unravelling the functions of Peptidyl-Prolyl Isomerase A in axonal transport and neuromuscular junction development and maintenance.
NSERC · 2021 · Principal investigator
6 publications.
Engineered autophagy receptors administered with extracellular vesicles eliminate pathological Tau and TDP-43.
Guo H, Savard A, Manser C, Dutta K, Taylor JA, Rousseaux MWC, Pozzi S, Julien JP, Baird S, Gibbings D
Antibody targeting TDP-43 mitigates pathogenic pathways induced by the cerebrospinal fluid of ALS.
Poulin-Brière A, Pozzi S, Julien JP
Tryptophan residues in TDP-43 and SOD1 modulate the cross-seeding and toxicity of SOD1.
Pokrishevsky E, DuVal MG, McAlary L, Louadi S, Pozzi S, Roman A, Plotkin SS, Dijkstra A, Julien JP, Allison WT, Cashman NR
Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
Pelaez MC, Desmeules A, Gelon PA, Glasson B, Marcadet L, Rodgers A, Phaneuf D, Pozzi S, Dutchak PA, Julien JP, Sephton CF
Transactive response DNA-binding protein 43 is enriched at the centrosome in human cells.
Bodin A, Greibill L, Gouju J, Letournel F, Pozzi S, Julien JP, Renaud L, Bohl D, Millecamps S, Verny C, Cassereau J, Lenaers G, Chevrollier A, Tassin AM, Codron P
Antibody-Based Therapeutic Interventions for Amyotrophic Lateral Sclerosis: A Systematic Literature Review.
Poulin-Brière A, Rezaei E, Pozzi S
Cellular communication in Amyotrophic Lateral Sclerosis: untangling a unique astrocytic pathway leading to neurodegeneration and neuroinflammation.
Principal investigators: Pozzi, Silvia
Keywords: Amyotrophic Lateral Sclerosis; Astrocytes; Cellular Communication; Microglia; Motor Neurons
Canada Research Chairs - Tier 2
Principal investigators: Pozzi, Silvia
Keywords: Crc
Unravelling the functions of Peptidyl-Prolyl Isomerase A in axonal transport and neuromuscular junction development and maintenance.
Principal investigators: Pozzi, Silvia
Unravelling the functions of Peptidyl-Prolyl Isomerase A in axonal transport and neuromuscular junction development and maintenance.
Principal investigators: Pozzi, Silvia
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Psychiatrie
- Cellular and Molecular Medicine
- Other
Co-authors at Université Laval, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.